4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-23-007510
Options or other derivatives
- HEAD OF R&D acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MODUR VIJAY · HEAD OF R&D
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-25 | Grant or award : show line 1 in the form Stock Options (Right to Buy) | +30,000 | 30,000 | D |
Loading xslF345X03/tm234565-1_4seq1.xml…